Publications

  1. Johnston SK, Whitmire P, Massey SC, Kumthekar P, Porter AB, Raghunand N, Gonzalez-Cuyar LF, Mrugala MM, Hawkins-Daarud A, Jackson PR, Hu LS, Sarkaria JN, Wang L, Gatenby RA, Egan KM, Canoll P, Swanson KR, ENDURES consortium. ENvironmental Dynamics Underlying Responsive Extreme Survivors (ENDURES) of Glioblastoma: A Multidisciplinary Team-based, Multifactorial Analytical Approach. Am J Clin Oncol. 2019 Aug; 42 (8):655-661
    View PubMed
  2. Valencia-Sanchez C, Gorelkin VC, Mrugala MM, Sharma A, Vora SA, Ashman JB, Daniels TB, Halyard MY, Rule WG, Zhang N, Butterfield RJ, Schild SE, Porter AB. Clinical evaluation of fitness to drive in patients with brain metastases. Neurol Oncol Pract. 2019 Jul.
  3. Sharma A, Grill MF, Spritzer S, Leis AA, Anderson M, Vig P, Porter AB. Malignant Glial Neuronal Tumors After West Nile Virus Neuroinvasive Disease: A Coincidence or a Clue? Neurohospitalist. 2019 Jul; 9 (3):160-164 Epub 2018 Dec 26
    View PubMed
  4. Cerhan JH, Anderson SK, Butts AM, Porter AB, Jaeckle K, Galanis E, Brown PD. Examiner accuracy in cognitive testing in multisite brain-tumor clinical trials: an analysis from the Alliance for Clinical Trials in Oncology. Neurooncol Pract. 2019 Jul; 6 (4):283-288 Epub 2018 Nov 24
    View PubMed
  5. Dhamija R, Wood CP, Porter AB, Hu LS, Weindling SM, Hoxworth JM. Updated Imaging Features of Dysplastic Cerebellar Gangliocytoma. J Comput Assist Tomogr. 2019 Mar/Apr; 43 (2):277-281
    View PubMed
  6. Ornelas AS, Porter AB, Sharma A, Knox MG, Marks LA, Wingerchuk DM, O'Carroll CB. What is the Role of Tumor-treating Fields in Newly Diagnosed Glioblastoma? Neurologist. 2019 Mar; 24 (2):71-73
    View PubMed
  7. Hu LS, Yoon H, Eschbacher JM, Baxter LC, Dueck AC, Nespodzany A, Smith KA, Nakaji P, Xu Y, Wang L, Karis JP, Hawkins-Daarud AJ, Singleton KW, Jackson PR, Anderies BJ, Bendok BR, Zimmerman RS, Quarles C, Porter-Umphrey AB, Mrugala MM, Sharma A, Hoxworth JM, Sattur MG, Sanai N, Koulemberis PE, Krishna C, Mitchell JR, Wu T, Tran NL, Swanson KR, Li J. Accurate Patient-Specific Machine Learning Models of Glioblastoma Invasion Using Transfer Learning. AJNR Am J Neuroradiol. 2019 Mar; 40 (3):418-425 Epub 2019 Feb 28
    View PubMed
  8. Fega KR, Fletcher GP, Waddle MR, Peterson JL, Ashman JB, Barrs DM, Bendok BR, Patel NP, Porter AB, Vora SA. Analysis of MRI Volumetric Changes After Hypofractionated Stereotactic Radiation Therapy for Benign Intracranial Neoplasms. Adv Radiat Oncol. 2019 Jan-Mar; 4 (1):43-49 Epub 2018 Aug 23
    View PubMed
  9. Rayfield CA, Grady F, De Leon G, Rockne R, Carrasco E, Jackson P, Vora M, Johnston SK, Hawkins-Daarud A, Clark-Swanson KR, Whitmire S, Gamez ME, Porter A, Hu L, Gonzalez-Cuyar L, Bendok B, Vora S, Swanson KR. Distinct Phenotypic Clusters of Glioblastoma Growth and Response Kinetics Predict Survival. JCO Clin Cancer Inform. 2018 Dec; 2:1-14
    View PubMed
  10. Dawit S, Porter AB. Low grade glioma in the setting of Wilson’s Disease. ACR Case in Point (accepted). 2018.
  11. Porter AB, Sio TT, Nelson KD, Raghunathan A, Bendok BR, Mrugala MM. Disseminated High-grade Glioma in a Long-term Survivor of Medulloblastoma: Implications and Management of Radiation-induced Malignancies. Neurologist. 2018 Nov; 23 (6):191-193
    View PubMed
  12. Yang M, Zhou Y, Hoxworth JM, Porter AB, Roarke MC. Hybrid whole body (18)F-FDG PET/MR in evaluation of plexiform neurofibromatosis type 1. Rev Esp Med Nucl Imagen Mol. 2018 Jul - Aug; 37 (4):261-263 Epub 2017 Aug 10
    View PubMed
  13. Dhamija R, Weindling SM, Porter AB, Hu LS, Wood CP, Hoxworth JM. Neuroimaging abnormalities in patients with Cowden syndrome: Retrospective single-center study. Neurol Clin Pract. 2018 Jun; 8 (3):207-213
    View PubMed
  14. Sharma A, De G, Porter A, Grill MF, Rosenthal A, Brown CE, Swanson K, Mrugala MM. CAR-T cell therapy in neuro-oncology: applications and toxicity. Neuroimmunol Neuroinflammation. 2018; 5(43).
  15. Grimsrud KW, Porter AB. Mystery Case: Widespread plexiform neurofibromas in neurofibromatosis type 1: An uncommon cause of back pain. Neurology. 2017 Oct 31; 89 (18):e218-e219
    View PubMed
  16. Uhm JH, Porter AB. Treatment of Glioma in the 21st Century: An Exciting Decade of Postsurgical Treatment Advances in the Molecular Era. Mayo Clin Proc. 2017 Jun; 92 (6):995-1004
    View PubMed
  17. Porter AB, Lachance DH, Johnson DR. Socioeconomic status and glioblastoma risk: a population-based analysis. Cancer Causes Control. 2015 Feb; 26 (2):179-185 Epub 2014 Nov 25
    View PubMed
  18. Porter A. Brainstem glioma doesn't stop former Marine. Clinical Neurology News. 2012 Aug:7-8.
  19. Flanagan EP, O'Neill BP, Habermann TM, Porter AB, Keegan BM. Secondary intramedullary spinal cord non-Hodgkin's lymphoma. J Neurooncol. 2012 May; 107 (3):575-80 Epub 2011 Dec 22
    View PubMed
  20. Flanagan EP, O'Neill BP, Porter AB, Lanzino G, Haberman TM, Keegan BM. Primary intramedullary spinal cord lymphoma. Neurology. 2011 Aug 23; 77(8):784-91. Epub 2011 Aug 10.
    View PubMed
  21. Porter AB, Bernold DM, Giannini C, Foote RL, Link MJ, Olsen KD, Moynihan TJ, Buckner JC. Retrospective review of adjuvant chemotherapy for esthesioneuroblastoma. J Neurooncol. 2008 Nov; 90 (2):201-4 Epub 2008 July 17
    View PubMed
  22. Cady FM, O'Neill BP, Law ME, Decker PA, Kurtz DM, Giannini C, Porter AB, Kurtin PJ, Johnston PB, Dogan A, Remstein ED. Del(6)(q22) and BCL6 rearrangements in primary CNS lymphoma are indicators of an aggressive clinical course. J Clin Oncol. 2008 Oct 10; 26(29):4814-9. Epub 2008 Jul 21.
    View PubMed
  23. Porter AB, Giannini C, Kaufmann T, Lucchinetti CF, Wu W, Decker PA, Atkinson JL, O'Neill BP. Primary central nervous system lymphoma can be histologically diagnosed after previous corticosteroid use: a pilot study to determine whether corticosteroids prevent the diagnosis of primary central nervous system lymphoma. Ann Neurol. 2008 May; 63(5):662-7.
    View PubMed
  24. Stead LG, Bellolio MF, Gilmore RM, Porter AB, Rabinstein AA. Pharmacologic elevation of blood pressure for acute brain ischemia. Neurocrit Care. 2008; 8 (2):259-61
    View PubMed
  25. Porter A. International Education Issues: a perspective on the practice of neurology in northern Kenya. Neurology. 2007 Oct 23; 69(17):1719-20.
    View PubMed
  26. Porter A, Lyons MK, Wingerchuk DM, Bosch EP. Spinal cord astrocytoma presenting as "idiopathic" intracranial hypertension. Clin Neurol Neurosurg. 2006 Dec; 108(8):787-9. Epub 2005 Nov 18.
    View PubMed
  27. Porter-Umphrey A, Rabinstein AA, Tippmann-Peikert M. Coma, hypertension, and brainstem imaging abnormalities in a paraplegic man with necrotizing fasciitis. Rev Neurol Dis. 2006 Summer; 3(3):129-30; discussion 136-8.
    View PubMed
  28. Porter-Umphrey A, Rabinstein AA, Tippmann-Peikert M. Case discussion: coma, hypertension, and brainstem imaging abnormalities in a paraplegic man with necrotizing fasciitis. Rev Neurol Dis. 2006; 3(3):136-8.
  29. Porter A, Gladstone JP, Dodick DW. Migraine and white matter hyperintensities. Current Pain and Headache Reports. 2005 Aug; 9(4):289-93.
    View PubMed